Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Raw Materials (2016 - 2021)

Medifast's Raw Materials history spans 9 years, with the latest figure at $13.8 million for Q3 2021.

  • For Q3 2021, Raw Materials rose 1.01% year-over-year to $13.8 million; the TTM value through Sep 2021 reached $13.8 million, up 1.01%, while the annual FY2020 figure was $13.4 million, 23.42% up from the prior year.
  • Raw Materials reached $13.8 million in Q3 2021 per MED's latest filing, up from $9.5 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $13.8 million in Q3 2021 to a low of $4.3 million in Q3 2017.
  • Average Raw Materials over 5 years is $9.6 million, with a median of $10.5 million recorded in 2019.
  • Peak YoY movement for Raw Materials: dropped 27.71% in 2017, then surged 212.16% in 2018.
  • A 5-year view of Raw Materials shows it stood at $4.3 million in 2017, then surged by 156.58% to $11.2 million in 2018, then dropped by 2.47% to $10.9 million in 2019, then increased by 23.42% to $13.4 million in 2020, then rose by 3.07% to $13.8 million in 2021.
  • Per Business Quant, the three most recent readings for MED's Raw Materials are $13.8 million (Q3 2021), $9.5 million (Q2 2021), and $11.2 million (Q1 2021).